Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gioeli

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Plos One|July 5, 2012
Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screenHilary Whitworth, Shriti Bhadel, Melissa Ivey, et al.
Ebiomedicine|June 23, 2016
Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanomaMouadh Benamar, Fadila Guessous, Kangping Du, et al.
Oncotarget|April 20, 2013
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanismsMark Axelrod, Vicki L Gordon, Mark Conaway, et al.
Molecular Cancer Therapeutics|September 11, 2012
Synthetic lethal screening with small-molecule inhibitors provides a pathway to rational combination therapies for melanomaDevin G Roller, Mark Axelrod, Brian J Capaldo, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 2009
SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cellsSanna Kaikkonen, Tiina Jääskeläinen, Ulla Karvonen, et al.
The Journal of Biological Chemistry|February 14, 2008
Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitroLeonard C Shank, Joshua B Kelley, Daniel Gioeli, et al.
Cancer Research|November 18, 2015
Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell GrowthHuy Q Ta, Melissa L Ivey, Henry F Frierson, et al.
Molecular Cancer Therapeutics|June 30, 2011
Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancerDaniel Gioeli, Winfried Wunderlich, Judith Sebolt-Leopold, et al.
Molecular Cancer|June 30, 2019
Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growthHuy Q Ta, Hilary Whitworth, Yi Yin, et al.
Molecular Endocrinology (Baltimore, Md.)|December 20, 2003
Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactionsBen E Black, Michael J Vitto, Daniel Gioeli, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Plos One|July 5, 2012
Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screenHilary Whitworth, Shriti Bhadel, Melissa Ivey, et al.
Ebiomedicine|June 23, 2016
Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanomaMouadh Benamar, Fadila Guessous, Kangping Du, et al.
Oncotarget|April 20, 2013
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanismsMark Axelrod, Vicki L Gordon, Mark Conaway, et al.
Molecular Cancer Therapeutics|September 11, 2012
Synthetic lethal screening with small-molecule inhibitors provides a pathway to rational combination therapies for melanomaDevin G Roller, Mark Axelrod, Brian J Capaldo, et al.
Molecular Endocrinology (Baltimore, Md.)|January 1, 2009
SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cellsSanna Kaikkonen, Tiina Jääskeläinen, Ulla Karvonen, et al.
The Journal of Biological Chemistry|February 14, 2008
Activation of the DNA-dependent protein kinase stimulates nuclear export of the androgen receptor in vitroLeonard C Shank, Joshua B Kelley, Daniel Gioeli, et al.
Cancer Research|November 18, 2015
Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell GrowthHuy Q Ta, Melissa L Ivey, Henry F Frierson, et al.
Molecular Cancer Therapeutics|June 30, 2011
Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancerDaniel Gioeli, Winfried Wunderlich, Judith Sebolt-Leopold, et al.
Molecular Cancer|June 30, 2019
Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growthHuy Q Ta, Hilary Whitworth, Yi Yin, et al.
Molecular Endocrinology (Baltimore, Md.)|December 20, 2003
Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactionsBen E Black, Michael J Vitto, Daniel Gioeli, et al.
Pageof 5